Share this article
Share this article
OTTAWA, ON, Jan. 22, 2021 /CNW/ - As we work toward our economic recovery from the COVID-19 pandemic and begin to build back better, it is more important than ever that the Government of Canada invests in services that are essential to the security and growth of Canadian agriculture and agri-food businesses.
The Government of Canada is investing $162.6 million in the Canadian Food Inspection Agency (CFIA) over the next five years and $40 million per year on an ongoing basis to maintain the integrity of Canada s food safety system, protect the health of plants and animals to safeguard the food supply, and provide ongoing support to Canadian businesses in their export and import activities to overcome pandemic interruptions and global trade volatility.
El Camino Health s Mountain View and Los Gatos Hospitals Receive Notable Fourth ANCC Magnet® Designation for Nursing Excellence
Less than 100 hospitals worldwide hold fourth-time designation
News provided by
Share this article
Share this article
MOUNTAIN VIEW, Calif., Jan. 21, 2021 /PRNewswire/ El Camino Health today announced that it has received Magnet® Designation by the American Nurses Credentialing Center (ANCC) for the fourth consecutive time for nursing excellence and quality patient care. Our team of talented nurses have absolutely earned this designation through their hard work and dedication to patient care, said Cheryl Reinking, El Camino Health s chief nursing officer. It s difficult to overstate the importance of this recognition for our entire team every single team member and patient at El Camino Health is better served thanks to our standout nurses and the program in place that helps them be their very best.
MIVI Neuroscience Secures Series B Funding
News provided by
Share this article
Share this article
EDEN PRAIRIE, Minn., Jan. 21, 2021 /PRNewswire/ MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including $35 million in new money plus the conversion of previously issued convertible notes. The funding was led by a major multinational med-tech company and included participation from new investors Perceptive Advisors, Deerfield Management and Aphelion / Cardeation Capital as well as existing investors including Concord Health Partners. Raymond James & Associates, Inc. acted as sole placement agent for the transaction.
CorNeat Vision s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Center, Ending a Decade of Blindness
USA - English
News provided by
Share this article
Share this article
RA ANANA, Israel, Jan. 11, 2021 /PRNewswire/ The CorNeat KPro, the first artificial cornea which completely integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor Irit Bahar, Director of the Ophthalmology Department. Upon removal of bandages, the CorNeat KPro immediately enabled the patient to read text and recognize family members. This exciting moment can be viewed in the following link.